Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
Reses H, Segovia G, Dubendris H, Barbre K, Ananth S, Lape-Newman B, Wong E, Stillions M, Rowe T, Mothershed E, Wallender E, Twentyman E, Wiegand R, Patel P, Benin A, Bell J. Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024. MMWR Morbidity And Mortality Weekly Report 2024, 73: 1052-1057. PMID: 39570790, PMCID: PMC11581205, DOI: 10.15585/mmwr.mm7346a2.Peer-Reviewed Original ResearchMeSH KeywordsAgedCOVID-19COVID-19 VaccinesHumansInfluenza VaccinesInfluenza, HumanNursing HomesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesUnited StatesVaccination CoverageConceptsRespiratory syncytial virusRespiratory syncytial virus vaccineNational Healthcare Safety NetworkSyncytial virusVaccination coverageSusceptible to severe outcomesHealth and Human Services regionsRespiratory virus seasonCOVID-19 vaccineCDC's National Healthcare Safety NetworkInfluenza vaccineVirus seasonSevere complicationsRespiratory virusesAssociated with respiratory illnessInfluenzaNursing home residentsSafety NetworkRespiratory illnessSevere outcomesReport vaccinationElevated riskSARS-CoV-2VaccineIndex levels